We are live on ! Find out more

3,309 hedge funds and large institutions have $160B invested in Merck in 2025 Q3 according to their latest regulatory filings, with 191 funds opening new positions, 1,354 increasing their positions, 1,424 reducing their positions, and 151 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 191 | Existing positions closed: 151

13% more call options, than puts

Call options by funds: $2.83B | Put options by funds: $2.51B

10% more funds holding in top 10

Funds holding in top 10: 4246 (+4)

1% more capital invested

Capital invested by funds: $158B → $160B (+$1.56B)

1% less funds holding

Funds holding: 3,3273,309 (-18)

5% less repeat investments, than reductions

Existing positions increased: 1,354 | Existing positions reduced: 1,424

2.19% less ownership

Funds ownership: 78.42%76.23% (-2.2%)

Holders
3,309
Holders Change
-18
Holders Change %
-0.54%
% of All Funds
43.43%
Holding in Top 10
46
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+9.52%
% of All Funds
0.6%
New
191
Increased
1,354
Reduced
1,424
Closed
151
Calls
$2.83B
Puts
$2.51B
Net Calls
+$326M
Net Calls Change
+$244M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$21.2B -$64M -777,516 -0.3%
BlackRock
2
BlackRock
New York
$18B -$285M -3,464,232 -2%
State Street
3
State Street
Massachusetts
$10B -$25.8M -313,686 -0.3%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.32B -$130M -1,577,388 -2%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$5.01B +$69.7M +846,193 +1%
Charles Schwab
6
Charles Schwab
California
$4.51B -$13.7M -166,006 -0.3%
Morgan Stanley
7
Morgan Stanley
New York
$3.74B +$31.8M +385,841 +0.9%
JP Morgan Chase
8
JP Morgan Chase
New York
$2.95B +$278M +3,379,875 +11%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$2.81B +$153M +1,860,625 +6%
Northern Trust
10
Northern Trust
Illinois
$2.34B -$66.9M -812,286 -3%
Bank of America
11
Bank of America
North Carolina
$2.22B -$129M -1,571,698 -6%
Fisher Asset Management
12
Fisher Asset Management
Washington
$2.02B -$77.9M -945,571 -4%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$1.83B -$16.7M -203,076 -0.9%
Legal & General Group
14
Legal & General Group
United Kingdom
$1.73B +$95.2M +1,156,112 +6%
Invesco
15
Invesco
Georgia
$1.67B +$232M +2,821,766 +17%
UBS AM
16
UBS AM
Illinois
$1.66B -$443M -5,383,464 -21%
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$1.57B -$61.6M -747,393 -4%
UBS Group
18
UBS Group
Switzerland
$1.42B +$428K +5,194 +0%
Deutsche Bank
19
Deutsche Bank
Germany
$1.41B -$16.2M -196,261 -1%
Franklin Resources
20
Franklin Resources
California
$1.41B -$847M -10,285,611 -38%
Amundi
21
Amundi
France
$1.35B -$109M -1,318,470 -8%
Ameriprise
22
Ameriprise
Minnesota
$1.34B +$225M +2,735,459 +21%
Goldman Sachs
23
Goldman Sachs
New York
$1.26B -$278M -3,370,286 -18%
State Farm Mutual Automobile Insurance
24
State Farm Mutual Automobile Insurance
Illinois
$1.16B
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$1.14B +$231M +2,803,331 +26%

MRK Hedge Fund Activity: Q3 2025 in Review

3,309 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2025, worth a combined $160B — up 0.99% from $158B a quarter earlier.

Buyers outnumbered sellers: 191 funds opened new MRK positions and 151 closed out — a net gain of 40 holders — while 1,354 added to existing stakes and 1,424 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $298M. The largest seller was Franklin Resources, cutting an estimated $847M.

  • 3,309 institutional investors held Merck (MRK) as of Q3 2025, down from 3,327 in Q2 2025.
  • Funds reported $160B of Merck stock for Q3 2025, up 0.99% quarter-over-quarter.
  • 191 funds opened new Merck positions in Q3 2025 and 151 closed out, a net change of +40 holders.
  • The largest Merck buyer in Q3 2025 was Assenagon Asset Management, an estimated $298M added.
  • The largest Merck seller in Q3 2025 was Franklin Resources, an estimated $847M sold.

Based on aggregated 13F filings for Q3 2025.